Gynecologic oncology group strategies to improve timeliness of publication

Clinical Trials

Volumn 10, Issue 4, 2013, Pages 617-623

  Bialy, Sally ^a   Blessing, John A ^a   Stehman, Frederick B ^b   Reardon, Anne M ^a   Blaser, Kim M ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATA BASE; GYNECOLOGY; HUMAN; INFORMATION PROCESSING; MEDICAL RESEARCH; MONITORING; ONCOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROCESS DEVELOPMENT; PUBLICATION; REVIEW;

COOPERATIVE BEHAVIOR; EDITORIAL POLICIES; FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGY; HUMANS; PUBLISHING; TIME FACTORS; UNITED STATES;

EID: 84881036245     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774513490249     Document Type: Review

References (6)

1. CONSORT. Available at: www.consort-statement.org (accessed 18 January 2012).
2. STARD. Available at: www.stard-statement.org (accessed 18 January 2012).
3. GPP2. Available at: http://www.ismpp.org/gpp2 (accessed 18 January 2012).
4. Dilts DM, Sandler AB, Cheng SK, et al. Steps and time to process clinical trials at the Cancer Therapy Evaluation Program. J Clin Oncol. 2009 ; 27: 1761-66
5. Dilts DM, Sandler AB. Activating and opening phase III clinical trials: A process and timing study. Slide Presentation at the 9/18/07 Cooperative Group Chairs Meeting ; Rockville, MD ;..
6. Blessing JA, Bialy SA, Whitney CW, Stonebraker BL, Stehman FB. Gynecologic Oncology Group quality assurance audits: Analysis and initiatives for improvement. Clin Trials. 2010 ; 7 (4). 390-99